A lead compound for the development of ABA 8′-hydroxylase inhibitors

被引:10
|
作者
Ueno, K
Yoneyama, H
Saito, S
Mizutani, M
Sakata, K
Hirai, N
Todoroki, Y [1 ]
机构
[1] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan
[2] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan
[3] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan
[4] Kyoto Univ, Int Innovat Ctr, Kyoto 6068501, Japan
基金
日本学术振兴会;
关键词
abscisic acid; ABA; cytochrome P450; ABA 8'-hydroxylase; inhibitor;
D O I
10.1016/j.bmcl.2005.08.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
(1'S*,2'S*)-(+/-)-6-Nor-2',3'-dihydro-4'-deoxo-ABA (2) was designed and synthesized as a candidate lead compound for developing a potent and specific inhibitor of ABA 8'-hydroxylase. This compound acted as an effective competitive inhibitor of the enzyme, with a K-I value of 0.40 mu M, without exhibiting ABA activity. However, compound 2 also functioned as an enzyme substrate, making it a short-lived inhibitor. The 8'-difluorinated derivative of 2 (4) was synthesized as a long-lasting alternative. Compound 4 resisted 8'-hydroxylation, but inhibited ABA 8'-hydroxylation as effectively as 2. These results suggest that compound 2 is a useful lead compound for the future design and development of an ideal ABA 8'-hydroxylase inhibitor. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5226 / 5229
页数:4
相关论文
共 50 条
  • [1] ABA 8′-hydroxylase and its chemical inhibitors
    Mizutani M.
    Todoroki Y.
    [J]. Phytochemistry Reviews, 2006, 5 (2-3) : 385 - 404
  • [2] 8'-acetylene ABA: An irreversible inhibitor of aba 8'-hydroxylase
    Rose, PA
    Cutler, AJ
    Irvine, NM
    Shaw, AC
    Squires, TM
    Loewen, MK
    Abrams, SR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (19) : 2543 - 2546
  • [3] A new lead compound for the development of Carbonic Anhydrase inhibitors
    Di Fiore, Anna
    De Simone, Giuseppina
    Vergara, Alessandro
    Caterino, Marco
    Alterio, Vincenzo
    Monti, Simona M.
    Ombouma, Joanna
    Dumy, Pascal
    Supuran, Claudiu T.
    Winum, Jean-Yves
    [J]. PROTEIN SCIENCE, 2015, 24 : 50 - 50
  • [4] Differences between the structural requirements for ABA 8′-hydroxylase inhibition and for ABA activity
    Ueno, K
    Araki, Y
    Hirai, N
    Saito, S
    Mizutani, M
    Sakata, K
    Todoroki, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (10) : 3359 - 3370
  • [5] Seed dormancy and ABA metabolism in Arabidopsis and barley: the role of ABA 8'-hydroxylase
    Millar, AA
    Jacobsen, JV
    Ross, JJ
    Helliwell, CA
    Poole, AT
    Scofield, G
    Reid, JB
    Gubler, F
    [J]. PLANT JOURNAL, 2006, 45 (06): : 942 - 954
  • [6] Enlarged analogues of uniconazole, new azole containing inhibitors of ABA 8′-hydroxylase CYP707A
    Todoroki, Yasushi
    Aoyama, Hikaru
    Hiramatsu, Saori
    Shirakuru, Minaho
    Nimitkeatkai, Hataitip
    Kondo, Satoru
    Ueno, Kotomi
    Mizutani, Masaharu
    Hirai, Nobuhiro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (19) : 5782 - 5786
  • [7] Analysis of Physcomitrella patens that overexpresses ABA 8'-hydroxylase
    Aragane, Atsushi
    Mizuguchi, Yuji
    Taji, Teruaki
    Tanaka, Shigeo
    Sakata, Yoichi
    [J]. PLANT AND CELL PHYSIOLOGY, 2007, 48 : S58 - S58
  • [8] Structural requirements for substrate recognition of ABA 8′-hydroxylase
    Ueno, K
    Araki, Y
    Todoroki, Y
    Saito, S
    Mizutani, M
    Sakata, K
    Hirai, N
    [J]. PLANT AND CELL PHYSIOLOGY, 2005, 46 : S50 - S50
  • [9] Expression Regulation of ABA 8′-Hydroxylase Gene by RNA Interference
    Chen Jing
    Zheng Han
    Chen Yi
    Ma Hua
    Liu Yan
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2010, 46 : S194 - S194
  • [10] Ephedrine as a lead compound for the development of new DPP-IV inhibitors
    Jose Ojeda-Montes, Maria
    Ardid-Ruiz, Andrea
    Tomas-Hernandez, Sarah
    Gimeno, Aleix
    Cereto-Massague, Adria
    Beltran-Debon, Raul
    Mulero, Miquel
    Garcia-Vallve, Santiago
    Pujadas, Gerard
    Valls, Cristina
    [J]. FUTURE MEDICINAL CHEMISTRY, 2017, 9 (18) : 2129 - 2146